Vanberra Signal

Novici Biotech

Curated by Signal

Developer of a technology platform for directed evolution of proteins and various applications

Overview

Developer of a technology platform for directed evolution of proteins and various applications. The company has a patented platform, called GRAMMR (Genetic ReAssortment by MisMatch Resolution) that can be used for protein engineering and empirical codon optimization. The company produces recombinant proteins such as antibodies, therapeutics, and vaccines in plants and provides DNA error correction technology for the synthetic biology industry.

Key facts

Founded
2007

Business model

Contact

More on Vanberra Signal

Members only

Competitors & similar companies

More Life Sciences Technology companies
  • Developer of a patch for cardiac health monitoring

    Life Sciences TechnologyLos Angeles, United States
  • Provider of non-invasive cardiac monitoring devices

    Life Sciences TechnologyEscondido, United States
  • Provider of vascular dopplers and surgical dopplers for vascular diseases

    Life Sciences TechnologySt. Louis, United States

About Novici Biotech

What does Novici Biotech do?

Developer of a technology platform for directed evolution of proteins and various applications.

Where is Novici Biotech headquartered?

Novici Biotech is headquartered in Vacaville, United States.

When was Novici Biotech founded?

Novici Biotech was founded in 2007.

Which sector is Novici Biotech in?

Novici Biotech operates in Life Sciences Technology.

Who are Novici Biotech's competitors?

Companies similar to Novici Biotech include DMS-Service, CB Scientific, and Koven Technology.